Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinsons Disease
December 05, 2025 21:00 ET | Source: Cerevance, Inc. Phase 2 results…
AVComparatives triumphs at 2025 “Tiroler Innovationspreis 2025”
INNSBRUCK, Austria, Dec. 5, 2025 /PRNewswire/ -- The independent cybersecurity testing authority AV‑Comparatives…
Kia Unveils the PBV Experience Center
Kia opens its first PBV Experience Center to accelerate its global PBV…
Zuellig Pharma Unveils State-of-the-art Clinical Trial Support Innovation Center in South Korea to Support both Domestic and Global Clinical Research Needs
Zuellig Pharma, a leading healthcare solutions company in Asia, today announced the…
Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program
November 28, 2025 20:13 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
Tianlong Strengthens Transfusion Safety with Innovative Blood Screening Solutions on World AIDS Day 2025
XI'AN, China, Nov. 28, 2025 /PRNewswire/ -- On World AIDS Day 2025,…
Hyundai Motor Group Drives NextGeneration Battery Innovation with Future Mobility Battery Campus
KRW 1.2 trillion investment to establish Hyundai Motor Group’s first comprehensive battery…
Cholan Tours Launches Women-Driven E-Auto Program in Madurai, Advancing Women’s Empowerment and Green Urban Mobility
MADURAI, India, Nov. 25, 2025 /PRNewswire/ -- Cholan Tours, one of India's…
The Bicester Collection announces the Winners of the Unlock Her Future Prize 2025 – South Asia Edition
Representing Bangladesh, India, Nepal, Pakistan and Bhutan, six bold innovators are advancing…
Rakovina Therapeutics Showcases Compelling Preclinical Data on AI-Discovered CNS-Penetrant ATR/mTOR Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting
VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc.…